Continuing Education Program (CEP)
On this page
About the CEP
Medicines Australia’s Continuing Education Program (CEP) is designed to educate medical representatives to a recognised industry standard.
The CEP is primarily directed at medical representatives working within the prescription medicines industry, but is also recommended to people who may not be currently employed within the industry but would like to pursue a career as a medical representative. It is also available to personnel working for organisations interacting with the pharmaceutical industry.
The CEP is currently offered online through the University of Tasmania’s Unit for Medication Outcomes Research and Education (UMORE), which is housed in the University’s Pharmacy Division.
For more information regarding program content or for enrolment details, please visit the University of Tasmania’s CEP website.
Medicines Australia holds student records and is able to provide transcripts upon request. If you are seeking a transcript, please see here.
The Continuing Education Program contains six core programs, designed to guide medical representatives through the information, knowledge and skills required in the performance of their professional duties.
The core programs are:
- Program 1: The Medicines Australia Code of Conduct – ethical practices within the pharmaceutical industry, including the obligations and practices of companies in their relationship with the health care industry and the public;
- Program 2: The Pharmaceutical and Healthcare Industry – the historic development of the industry, government regulatory processes and the industry’s role in the Australian health care system;
- Program 3: Human Anatomy and Physiology – introductory anatomy, physiology, cellular life, tissues, defence mechanisms, and an overview of nine body systems. This program is a pre-requisite for ‘Introduction to Pharmacology’. Recognition of Prior Learning (RPL) may be available for this course for students who have relevant qualifications;
- Program 4: An Introduction to Pharmacology – pharmacokinetics and pharmacodynamics, how drugs are administered, transported through the body and absorbed;
- Program 5: Understanding Product Information – an overview of the scientific, medical and therapeutic information contained in Product Information, including how the information is structured to comply with Therapeutic Goods Administration requirements; and
- Program 6: Understanding Clinical Evidence – a systematic approach to the analysis of published clinical papers, including how clinical trials are designed and conducted, and the four phases of clinical trials.
Code of Conduct Bridging Course
Medicines Australia makes available a short bridging course which provides an overview of the Code of Conduct and the key provisions it contains, as well as detailing changes made with any new edition of the Code. This program is designed for people who have an interest in the Code of Conduct and it’s application, as well as for returning students who have completed Program 1 of the CEP within the previous 3 academic years.
The Code of Conduct Bridging Course is not compulsory, and does not form part of the core CEP subjects. However it is recommended that students undertake this program to keep up-to-date with changes to the Code of Conduct as it evolves over time. Records for the completion of any update/refresher or bridging courses are not held by Medicines Australia and therefore it will not appear on any student transcripts issued by Medicines Australia.
Students may either enrol in a Program as an independent student or receive company sponsorship. Students with company sponsorship should consult with their Company Coordinator before attempting to enrol as most companies are issued with enrolment keys to facilitate their enrolment. To get started all students must create a user account on the UMORE iLearn Education Site. Company Sponsored students with an enrolment key should proceed by clicking onto their desired program, where they will be prompted to enter their enrolment key. Independent students can enrol in a specific Program by clicking on the ‘apply for independent enrolment’ tab which is found under Student Information on the home page. For further information click on the ‘getting started’ tab on the home page the UMORE iLearn Education Site which provides students with access to all key information. Assistance can also be obtained by contacting the University of Tasmania via email at MedicinesAustralia.CEP@utas.edu.au , via phone at 1300 305 228, or through the UMORE iLearn Education website.
Medicines Australia CEP awards are presented annually to students who achieve the highest marks in the course. Additionally, the University of Tasmania offers a prize to students based on the level of engagement and quality of participation in the course. Additional information regarding the awards can be found here (please follow link)
Key dates for the 2020 Academic Year
|Enrolment Opens||Monday, 13th January|
|Enrolments Close||Friday, 8th May|
|Semester Close/Last Day of Assessment||Friday, 5th June|
|Results and Certification||Friday, 12th June|
|Enrolment Opens||Monday, 29th June|
|Enrolments Close||Monday, 26th October|
|Semester Close/Last Day of Assessment||Friday, 20th November|
|Results and Certification||Friday, 27th November|
CEP Fees for 2020
*Fees Invoiced per program, per student.
|MA Member||$710.00 GST incl.|
|MA Non-Member||$1,010.00 GST incl.|
|Full CEP MA Member Fee||$4,260.00 GST incl.|
|Full CEP Non-Member Fee||$6,060.00 GST incl.|
|Code of Conduct Bridging Course||$100.00 GST incl.|
Students employed with a pharmaceutical company should contact their Company CEP Coordinator in the first instance.
For all other enquiries, please contact:
University of Tasmania
Phone: 1300 305 228
Phone: (02) 6147 6500